ICON is a global provider of outsourced drug and device development and commercialisation services. ICON specialises in the strategic development, management, and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. ICON applies innovation to drive emerging therapies forward and improve patient’s lives.

ICON has partnered with Veradigm to enable clinical research as a care option. Together, ICON and Veradigm are creating the industry’s leading EHR-based Site Network. The network aims to:

• Minimise physician administrative burden
• Expand patient access to clinical research
• Increase diversity of clinical trial populations
• Accelerate trial recruitment, bringing new approved treatments to patients faster